MKS Instruments CapEx decreased by 50.0% to $25.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.9%, from $18.00M to $25.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 14.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.00M | $20.50M | $24.00M | $19.00M | $64.00M | $26.00M | $55.00M | $17.00M | $18.00M | $18.00M | $34.00M | $18.00M | $27.00M | $22.00M | $51.00M | $18.00M | $29.00M | $51.00M | $50.00M | $25.00M |
| QoQ Change | — | +28.1% | +17.1% | -20.8% | +236.8% | -59.4% | +111.5% | -69.1% | +5.9% | +0.0% | +88.9% | -47.1% | +50.0% | -18.5% | +131.8% | -64.7% | +61.1% | +75.9% | -2.0% | -50.0% |
| YoY Change | — | — | — | — | +300.0% | +26.8% | +129.2% | -10.5% | -71.9% | -30.8% | -38.2% | +5.9% | +50.0% | +22.2% | +50.0% | +0.0% | +7.4% | +131.8% | -2.0% | +38.9% |